ConductScience.org, home

Paper38420192

From genes to drugs: CYP2C19 and pharmacogenetics in clinical practice.

Shubbar Q and 5 others. Front Pharmacol, 2024. Cited by 35 papers, by iCite.

Cite this record

ConductScience Library. From genes to drugs: CYP2C19 and pharmacogenetics in clinical practice. Papers, record 38420192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38420192

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
From genes to drugs: CYP2C19 and pharmacogenetics in clinical practice.
PubMed
Journal
Front Pharmacol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
8.37, provisional
iCite
Revised in PubMed
2024-03-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shubbar QQamar
2Alchakee AAminah
3Issa KWKhaled Walid
4Adi AJAbdul Jabbar
5Shorbagi AIAli Ibrahim
6Saber-Ayad MMaha

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References64

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132506666CYP2C19 Allele Frequencies in Over 2.2 Million Direct-to-Consumer Genetics Research Participants and the Potential Implication for Prescriptions in a Large Health System.Clin Transl Sci2020https://conductscience.org/library/papers/32506666PubMed
230554109Does obtaining CYP2D6 and CYP2C19 pharmacogenetic testing predict antidepressant response or adverse drug reactions?Psychiatry Res2019https://conductscience.org/library/papers/30554109PubMed
311454728Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram.Drug Metab Dispos2001https://conductscience.org/library/papers/11454728PubMed
437287029Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study.Hum Genomics2023https://conductscience.org/library/papers/37287029PubMed
523486447Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.Clin Pharmacol Ther2013https://conductscience.org/library/papers/23486447PubMed
635156424CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings.J Am Heart Assoc2022https://conductscience.org/library/papers/35156424PubMed
724322971Cardiovascular pharmacogenomics: expectations and practical benefits.Clin Pharmacol Ther2014https://conductscience.org/library/papers/24322971PubMed
833260705Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative.J Pers Med2020https://conductscience.org/library/papers/33260705PubMed
935890168Clinical Impact of Functional CYP2C19 and CYP2D6 Gene Variants on Treatment with Antidepressants in Young People with Depression: A Danish Cohort Study.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/35890168PubMed
1030837874Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders.Front Pharmacol2019https://conductscience.org/library/papers/30837874PubMed
1133551797
Impact of Implementing CYP2C19 Genotype-Guided Antiplatelet Therapy on P2Y12 Inhibitor Selection and Clinical Outcomes in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention: A Real-World Study in China.
Front Pharmacol2020https://conductscience.org/library/papers/33551797PubMed
1223670120Challenges and limitations in the interpretation of systematic reviews: making sense of clopidogrel and CYP2C19 pharmacogenetics.Clin Pharmacol Ther2013https://conductscience.org/library/papers/23670120PubMed
1327304207CYP2C19 and CYP2D6 genotypes in Pacific peoples.Br J Clin Pharmacol2016https://conductscience.org/library/papers/27304207PubMed
1431849282Cost-effectiveness of CYP2C19 LOF-guided antiplatelet therapy in Chinese patients with acute coronary syndrome.Pharmacogenomics2020https://conductscience.org/library/papers/31849282PubMed
1523333322Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.Pharmacol Ther2013https://conductscience.org/library/papers/23333322PubMed
1636333412Effect of CYP2C19 polymorphisms on antidepressant prescription patterns and treatment emergent mania in bipolar disorder.Pharmacogenomics J2023https://conductscience.org/library/papers/36333412PubMed
1732572118Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia.Sci Rep2020https://conductscience.org/library/papers/32572118PubMed
1836739136A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.Lancet2023https://conductscience.org/library/papers/36739136PubMed
1937032427Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.Clin Pharmacol Ther2023https://conductscience.org/library/papers/37032427PubMed
2020801494Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis.Lancet2010https://conductscience.org/library/papers/20801494PubMed

See all 64 referencesDownload CSV of references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
42943264Oxidative Susceptibility of Coumarin-1,2,3-Triazole-Isatin Hybrids: Integrating In Silico CYP-Mediated Metabolism Prediction with Electrochemistry-Mass Spectrometry.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943264PubMed
42891844Pharmacogenetic Impact of CYP2C19 Variants on Diazepam Treatment Outcomes in Alcohol Withdrawal Syndrome.Mol Neurobiol2026https://conductscience.org/library/papers/42891844PubMed
42836503The Role of Exosomal Biomarkers in the Monitoring of Bioactivation and Metabolite Clearance of Chemotherapeutics in Cancer Patients.Curr Drug Metab2026https://conductscience.org/library/papers/42836503PubMed
42807667Pharmacogenomics in the United Arab Emirates: advances in population genomics and challenges in clinical implementation.Front Pharmacol2026https://conductscience.org/library/papers/42807667PubMed
42683981Distribution of CYP2C19 polymorphism and predicted metabolizer phenotypes in the Indian population: A systematic review.Indian J Pharmacol2026https://conductscience.org/library/papers/42683981PubMed
42491921Impact of UGT1A9 Expression on Analgesic Efficacy and Safety of Postoperative Ketorolac in Thyroid Cancer Surgery: A Prospective Cohort Study.J Pain Res2026https://conductscience.org/library/papers/42491921PubMed
42445529Several antiplatelet gene SNPs, their haplotypes and G × E interactions on premature coronary artery disease.Front Cardiovasc Med2026https://conductscience.org/library/papers/42445529PubMed
42356431CYP450 Metabolizer Phenotypes in a Turkish Emergency Cardiac Patient Cohort: A Descriptive Pharmacogenomic Study.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42356431PubMed
42328638Integrating CRISPR functional genomics with admixture-aware psychotropic pharmacogenetics in Brazil.Front Pharmacol2026https://conductscience.org/library/papers/42328638PubMed
42219154Evaluation of a pantoprazole and 4-desmethylpantoprazole-sulfate metabolic ratio as a novel CYP2C19 phenotyping method.Br J Clin Pharmacol2026https://conductscience.org/library/papers/42219154PubMed
42168535Pharmacogenomic landscape of a Moroccan cohort: enhancing global diversity and addressing the North African gap.Sci Rep2026https://conductscience.org/library/papers/42168535PubMed
42041360Targeting Bacterial Infections in Periodontal Disease: From Conventional Antibiotics to Next-Generation Therapeutics.Antibiotics (Basel)2026https://conductscience.org/library/papers/42041360PubMed
42037677Clinical efficacy of drug-eluting stents in the treatment of vertebral artery stenosis and analysis of factors contributing to stent restenosis.Front Neurol2026https://conductscience.org/library/papers/42037677PubMed
41948562Type 2 diabetes mellitus as a state of altered drug pharmacokinetic-pharmacodynamic parameters: an update on recent developments and clinical implications.Ther Adv Endocrinol Metab2026https://conductscience.org/library/papers/41948562PubMed
41803106Computational variant predictors for pharmacogenomics: from evaluation of single alleles to assessment of adverse drug reactions to antidepressants.Pharmacogenomics J2026https://conductscience.org/library/papers/41803106PubMed
41529816Actionable medications in Australian Vietnam War veterans: Implications for pre-emptive pharmacogenetic testing.Australas Psychiatry2026https://conductscience.org/library/papers/41529816PubMed
41518218Self-Reported Pharmacogenetic Medication Use in the Our Future Health Cohort.Clin Transl Sci2026https://conductscience.org/library/papers/41518218PubMed
41241757Empirical Drug Dosage Validates Pharmacogenomic Associations in All of Us.Clin Transl Sci2025https://conductscience.org/library/papers/41241757PubMed
41196651Implementation of clopidogrel pharmacogenetics: a Brazilian perspective.Pharmacogenomics2025https://conductscience.org/library/papers/41196651PubMed
41158125The impact of the exposome on cytochrome P450-mediated drug metabolism.Front Pharmacol2025https://conductscience.org/library/papers/41158125PubMed

See all 28 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CYP2C191557PubTator's text mininghttps://conductscience.org/library/genes/1557

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38420192

GET https://conductscience.org/api/papers/v1/38420192/references?page=2